Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Dual-mobility vs unipolar cups for primary total hip replacement via direct anterior approach

Official title: Monocentric Randomised Controlled Trial Comparing Dual-mobility Cups Versus Unipolar Cups for Unselected Primary Total Hip Arthroplasty by Direct Anterior Approach

Run by Elsan · NCT07464665 · Data updated 2026-11-12

This trial tests whether using a dual-mobility cup in primary total hip arthroplasty with a direct anterior approach reduces dislocation risk compared with a unipolar cup.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorElsan
Academic / other
Locations1 site (Bruges)
StatusRecruiting
StartedJuly 7, 2026
Main results expectedJuly 1, 2030
Study endsJuly 1, 2030
Registry record updatedJuly 16, 2026
Trial IDNCT07464665 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older undergoing elective primary THA via direct anterior approach, who speak French and are affiliated with a social security scheme, without prior ipsilateral hip surgery and meeting all other criteria.

Probably not a fit

Patients with conditions or anatomy that preclude DM cups (e.g., cup diameters incompatible with available implants) or those at high risk where no benefit is expected may not experience improvement.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two hip replacement components in adults undergoing elective primary total hip arthroplasty via the direct anterior approach. Participants are assigned to receive either a dual-mobility cup or a unipolar cup. The trial uses standard clinical procedures and follow-up to monitor outcomes such as dislocation risk, functional recovery, and safety. Eligibility requires French-speaking adults with prior hip condition suitable for primary THA and no prior ipsilateral hip surgery, among other criteria. The study is sponsored by Elsan and conducted at Polyclinique Jean Villar in Bruges, France.

Why it matters

Potential benefit: If successful, patients could experience a lower risk of hip dislocation and improved stability after hip replacement.

How similar studies have gone: Prior clinical work and systematic reviews suggest dual-mobility designs may reduce dislocation, but results vary by context and implant type.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* men and women aged ≥18 years old
* set to undergo elective primary THA via direct anterior approach (DAA)
* affiliated with a social security scheme
* able to answer questionnaires and to communicate freely in French
* who have been informed and have provided free, informed, and written consent (no later than the day of inclusion and before any examination required by the study)

Exclusion Criteria:

* with prior ipsilateral hip surgery
* with prior contralateral hip surgery
* that require acetabular cup diameters ≤50mm (because DM cups are not available from the same manufacturer for diameters ≤50mm, and UP cups require head diameters of 36mm and thus minimum cup diameters of 52mm)
* undergoing emergency or trauma surgery (e.g. femoral neck fractures)
* with any concomitant disease or disorder which, in the opinion of the surgeon, may put the patient at risk, notably of hip instability or dislocation (hip dysplasia, neuromuscular deficit, fracture sequelae…) or may influence the result of the study
* that are pregnant or breastfeeding
* under legal protection (guardianship or curatorship or deprived of liberty).

Where it's running

  • Polyclinique Jean Villar
    Bruges, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.